Vacuum-Sealing as a Treatment Option for Severe Anthracycline Extravasation in a Breast Cancer Patient.
BACKGROUND: Compared to peripheral venous access, central lines greatly reduce the incidence of cytotoxic extravasation. Although implantable vascular systems are widely used in oncology, extended extravasation lesions in cancer patients remain complicated. PATIENT AND METHOD: A 67-year-old female breast cancer patient suffered from an extended lesion of a catheter port extravasation. A vacuum-sealing therapy was initiated to accelerate the healing of the anthracycline-induced wound. RESULT: The vacuum-sealing technique allowed a fast and successful treatment of the extravasation lesion. CONCLUSION: Due to the myelosuppressive chemotherapy regimen, the risk of wound infections and prolonged healing processes is increased in cancer patients. Moreover, disruption or cancellation of anticancer therapies worsens the patients' prognosis. To attenuate these complications the vacuum-sealing technique should be considered in wound management concepts.
Rhiem
Kerstin
K
Department of Obstetrics and Gynecology, University of Cologne School of Medicine, Moers, Germany.
Nemat
André T
AT
Schmutzler
Rita K
RK
Krick
Matthias
M
Mallmann
Peter
P
Warm
Mathias
M
Oncologist. 2008 Apr;13(4):445-50
18448560
Ann Oncol. 2007 Mar;18(3):546-50
17185744
Cancer Treat Rep. 1984 Jun;68(6):895-6
6733702
Ann Plast Surg. 2002 Oct;49(4):369-74
12370641
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001898
18646080
Ann Oncol. 2004 Feb;15(2):296-300
14760125